Arcturus Therapeutics Holdings, Inc. (ARCT)
8.40
-0.47
(-5.30%)
USD |
NASDAQ |
Apr 29, 16:00
8.40
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Research and Development Expense (TTM) : 95.30M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 76.11M |
| STAAR Surgical Co. | 41.61M |
| Denali Therapeutics, Inc. | 418.78M |
| Quantum-Si, Inc. | 53.76M |
| Agenus, Inc. | 79.34M |